Published in World J Gastroenterol on April 01, 2003
Expression of NF-kappaB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World J Gastroenterol (2004) 1.09
Influence of liver nonparenchymal cell infusion combined with cyclosporin A on rejection of rat small bowel transplantation. World J Gastroenterol (2003) 0.78
NF-kappa B: ten years after. Cell (1996) 12.80
A surgical experience with five hundred thirty liver transplants in the rat. Surgery (1983) 2.48
Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem (1997) 2.15
Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc Natl Acad Sci U S A (1996) 1.85
High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation (1997) 1.65
The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J Exp Med (2001) 1.38
Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway. J Biol Chem (1995) 1.35
Nuclear factor kB activity in patients with acute severe cholangitis. World J Gastroenterol (2002) 1.09
Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts. Transplantation (1999) 1.01
Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clin Immunol (2002) 1.00
Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood (2000) 0.99
Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration. Am J Respir Crit Care Med (1999) 0.99
Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation. J Immunol (2002) 0.99
Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect". Hepatology (1993) 0.93
Selectin-mediated interactions regulate cytokine networks and macrophage heme oxygenase-1 induction in cardiac allograft recipients. Lab Invest (2002) 0.89
Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression. Hepatology (1998) 0.88
Expression of gamma-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients. Clin Transplant (1999) 0.88
Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: early activation and apoptosis is associated with liver graft acceptance. Transplantation (1998) 0.88
Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB. Mol Cell Biol (1998) 0.87
Bile duct injury as a part of diagnostic criteria for liver allograft rejection. Hum Pathol (1989) 0.86
Pancreatic islet allograft immunity and tolerance: the two-signal hypothesis revisited. Immunol Rev (1996) 0.86
Nuclear translocation of green fluorescent protein-nuclear factor kappaB with a distinct lag time in living cells. FEBS Lett (1999) 0.81
Interleukin-18 production following murine cardiac transplantation: correlation with histologic rejection and the induction of INF-gamma. J Interferon Cytokine Res (2001) 0.81
Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Transplantation (1998) 0.80
Enhancement of mast cell survival: a novel function of some secretory phospholipase A(2) isotypes. J Immunol (2001) 0.79
Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporine. Transplantation (2000) 0.78
Neonatal intrathymic splenocyte injection yields prolonged cardiac xenograft survival. Acta Med Okayama (1998) 0.77
Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways. J Heart Lung Transplant (2000) 0.77
Comparison of the abilities of MHC-compatible bone marrow cells and lymph node cells to induce tolerance of skin allografts in rats. Transplantation (1993) 0.77
Different in vivo tolerogenicity of MHC class I peptides. J Leukoc Biol (1999) 0.77
Severity of liver transplantation rejection is associated with recipient HLA type. Transplant Proc (1992) 0.77
Tolerance induction by intrathymic inoculation prevents chronic renal allograft rejection. Transplantation (1998) 0.77
The effect of thymic inoculation to induce tolerance of allogeneic thyroid grafts in the outbred rabbit. Histol Histopathol (1998) 0.76
Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol (2011) 3.88
Diagnosis and treatment of solid-pseudopapillary tumor of the pancreas. Hepatobiliary Pancreat Dis Int (2006) 1.71
Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia-reperfusion injury. J Gastroenterol Hepatol (2006) 1.48
Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS One (2011) 1.34
Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1 blaOXA-23 genes in a Chinese hospital. J Med Microbiol (2007) 1.20
Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience. Hepatobiliary Pancreat Dis Int (2008) 1.07
FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition. Int J Biol Sci (2012) 1.07
The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells. Proteomics (2010) 1.06
Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma. PLoS One (2010) 1.05
Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation (2008) 1.05
Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl (2011) 1.02
Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis. Liver Transpl (2012) 1.02
Pancreatic fistula after pancreaticoduodenectomy: diagnosed according to International Study Group Pancreatic Fistula (ISGPF) definition. Pancreatology (2007) 1.01
Advances in China's organ transplantation achieved with the guidance of law. Chin Med J (Engl) (2015) 0.99
Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer. Hepatobiliary Pancreat Dis Int (2008) 0.98
Protective effect of pyrrolidine dithiocarbamate on liver injury induced by intestinal ischemia-reperfusion in rats. Hepatobiliary Pancreat Dis Int (2006) 0.97
Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol (2004) 0.97
Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation. Hepatobiliary Pancreat Dis Int (2009) 0.96
Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells. Hepatobiliary Pancreat Dis Int (2008) 0.93
Cryopreservation of human ovarian tissue: comparison of novel direct cover vitrification and conventional vitrification. Cryobiology (2009) 0.93
Effects of low central venous pressure during preanhepatic phase on blood loss and liver and renal function in liver transplantation. World J Surg (2010) 0.92
Castleman disease mimicked pancreatic carcinoma: report of two cases. World J Surg Oncol (2012) 0.92
Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Ann Surg Oncol (2008) 0.92
Distinct intragraft response pattern in relation to graft size in liver transplantation. Transplantation (2003) 0.92
Incidence of unexplained intra-abdominal free fluid in patients with blunt abdominal trauma. Hepatobiliary Pancreat Dis Int (2009) 0.91
Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Cancer Prev Res (Phila) (2013) 0.90
Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol (2011) 0.90
Formation of Kv2.1-FAK complex as a mechanism of FAK activation, cell polarization and enhanced motility. J Cell Physiol (2008) 0.90
Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2. World J Gastroenterol (2005) 0.90
Symptomatic adult annular pancreas: report of two cases and a review of the literature. Hepatobiliary Pancreat Dis Int (2005) 0.89
Surgical therapy and prognosis of sarcomatoid carcinoma of the gallbladder. Hepatobiliary Pancreat Dis Int (2010) 0.89
Hepatocellular carcinoma with indolent T-lymphoblastic proliferation. Leuk Lymphoma (2006) 0.89
Posttransplantation lymphoproliferative disorder involving the central nervous system in liver transplant recipients. Hepatobiliary Pancreat Dis Int (2008) 0.89
Prophylaxis with carnosol attenuates liver injury induced by intestinal ischemia/reperfusion. World J Gastroenterol (2009) 0.89
The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Dig Dis Sci (2008) 0.89
Variations and reconstruction of the hepatic artery in liver transplantation. Hepatobiliary Pancreat Dis Int (2006) 0.87
Effect of nuclear factor kappa B on intercellular adhesion molecule-1 expression and neutrophil infiltration in lung injury induced by intestinal ischemia/reperfusion in rats. World J Gastroenterol (2006) 0.87
Ischemic preconditioning attenuates morphological and biochemical changes in hepatic ischemia/reperfusion in rats. Pathobiology (2010) 0.87
Triiodothyronine attenuates hepatic ischemia/reperfusion injury in a partial hepatectomy model through inhibition of proinflammatory cytokines, transcription factors, and adhesion molecules. J Surg Res (2012) 0.87
Microsurgical reconstruction of hepatic artery in living donor liver transplantation: experiences and lessons. Hepatobiliary Pancreat Dis Int (2009) 0.86
Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation. World J Gastroenterol (2003) 0.86
The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways. Hepatobiliary Pancreat Dis Int (2003) 0.86
A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation. Liver Int (2007) 0.86
Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. Brain Res Mol Brain Res (2005) 0.86
An effective model for predicting acute kidney injury after liver transplantation. Hepatobiliary Pancreat Dis Int (2010) 0.86
Assessment of biological characteristics of mesenchymal stem cells labeled with superparamagnetic iron oxide particles in vitro. Mol Med Rep (2011) 0.86
The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis. Hepatobiliary Pancreat Dis Int (2002) 0.86
Changes of gut bacteria and immune parameters in liver transplant recipients. Hepatobiliary Pancreat Dis Int (2012) 0.86
Long-term results of laparoscopic fenestration for patients with congenital liver cysts. Hepatobiliary Pancreat Dis Int (2007) 0.86
The diversity between pancreatic head and body/tail cancers: clinical parameters and in vitro models. Hepatobiliary Pancreat Dis Int (2013) 0.86
Assessment of the fecal lactobacilli population in patients with hepatitis B virus-related decompensated cirrhosis and hepatitis B cirrhosis treated with liver transplant. Microb Ecol (2011) 0.86
Activation of innate immunity (NK/IFN-gamma) in rat allogeneic liver transplantation: contribution to liver injury and suppression of hepatocyte proliferation. Am J Physiol Gastrointest Liver Physiol (2008) 0.85
Management of the middle hepatic vein and its tributaries in right lobe living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2007) 0.85
Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective. Hepatobiliary Pancreat Dis Int (2005) 0.85
Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment. Acta Pharmacol Sin (2007) 0.85
China organ donation and transplantation update: the Hangzhou Resolution. Hepatobiliary Pancreat Dis Int (2014) 0.84
Authorship in Hepatobilary & Pancreatic Diseases International. Hepatobiliary Pancreat Dis Int (2012) 0.84
Effects of suppressing glucose transporter-1 by an antisense oligodeoxynucleotide on the growth of human hepatocellular carcinoma cells. Hepatobiliary Pancreat Dis Int (2011) 0.84
Liver transplantation in China: problems and their solutions. Hepatobiliary Pancreat Dis Int (2004) 0.84
The influence of the severity of chronic virus-related liver disease on propofol requirements during propofol-remifentanil anesthesia. Yonsei Med J (2013) 0.84
Protective effect of probiotics on intestinal barrier function in malnourished rats after liver transplantation. Hepatobiliary Pancreat Dis Int (2011) 0.84
Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature. World J Gastroenterol (2007) 0.84
Considerations for two inoculation methods of rabbit hepatic tumors: Pathology and image features. Exp Ther Med (2011) 0.84
Cytomegalovirus and chronic allograft rejection in liver transplantation. World J Gastroenterol (2004) 0.83
Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol (2010) 0.83
Ischemic preconditioning enhances hepatocyte proliferation in the early phase after ischemia under hemi-hepatectomy in rats. Hepatobiliary Pancreat Dis Int (2012) 0.83
Current status and perspective of liver preservation solutions. Hepatobiliary Pancreat Dis Int (2006) 0.83
Association of polymorphisms in non-classic MHC genes with susceptibility to autoimmune hepatitis. Hepatobiliary Pancreat Dis Int (2012) 0.83
Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation. BMC Cancer (2010) 0.83
Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients. Asian Pac J Cancer Prev (2012) 0.83
Clinical experience in diagnosis and treatment of glucagonoma syndrome. Hepatobiliary Pancreat Dis Int (2004) 0.83
Mycophenolate mofetil attenuates liver ischemia/reperfusion injury in rats. Transpl Int (2009) 0.82
Single-operator wire-guided cannulation technique enables easier cannulation of endoscopic retrograde cholangiopancreatography. Dig Dis Sci (2012) 0.82
Tumor ablation with nanosecond pulsed electric fields. Hepatobiliary Pancreat Dis Int (2012) 0.82
Safety and efficiency of left hemihepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma with artery infiltration: report of 2 cases. Can J Surg (2008) 0.82
Clinical practice of early extubation after liver transplantation. Hepatobiliary Pancreat Dis Int (2012) 0.82
Retracted Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats. Stroke (2005) 0.82
Inhibitory effect of cyclosporine A on hepatitis B virus replication in vitro and its possible mechanisms. Hepatobiliary Pancreat Dis Int (2005) 0.82
Intraoperative blood salvage and leukocyte depletion during liver transplantation with bacterial contamination. Clin Transplant (2009) 0.82
Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity. J Gastroenterol Hepatol (2008) 0.82
Combination of genistein with ionizing radiation on androgen-independent prostate cancer cells. Asian J Androl (2004) 0.81
Major influence of renal function on hyperlipidemia after living donor liver transplantation. World J Gastroenterol (2012) 0.81
Expression of cyclooxygenase-2 in gastric cancer and its relation to liver metastasis and long-term prognosis. World J Gastroenterol (2005) 0.81
Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation. Hepatobiliary Pancreat Dis Int (2008) 0.81
Expression pattern of matrix metalloproteinases-13 in a rat model of alcoholic liver fibrosis. Hepatobiliary Pancreat Dis Int (2005) 0.81
FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition. Hepatobiliary Pancreat Dis Int (2014) 0.81
In vitro labeling of endothelial progenitor cells isolated from peripheral blood with superparamagnetic iron oxide nanoparticles. Mol Med Rep (2012) 0.81
Construction and biological activities of human tPA eukaryotic expression plasmid. Hepatobiliary Pancreat Dis Int (2004) 0.81
Calcitriol inhibits the growth of MHCC97 heptocellular cell lines by down-modulating c-met and ERK expressions. Liver Int (2007) 0.80
Pretreatment of hypertonic saline can increase endogenous interleukin 10 release to attenuate hepatic ischemia reperfusion injury. Dig Dis Sci (2006) 0.80
Effects of intestinal lymph on expression of neutrophil adhesion factors and lung injury after trauma-induced shock. World J Gastroenterol (2004) 0.80
Risk factors of choledocholithiasis formation after liver transplantation. Hepatobiliary Pancreat Dis Int (2013) 0.80
Kupffer cells contribute to concanavalin A-induced hepatic injury through a Th1 but not Th17 type response-dependent pathway in mice. Hepatobiliary Pancreat Dis Int (2011) 0.80
Expression of HLA-G in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2011) 0.80
Clinical management of hepatitis B virus infection correlated with liver transplantation. Hepatobiliary Pancreat Dis Int (2010) 0.80
Treatment of pancreatic pseudocysts in line with D'Egidio's classification. World J Gastroenterol (2005) 0.80
NF-kappa B in allograft rejection. Hepatobiliary Pancreat Dis Int (2003) 0.80
Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy. Clin Chem Lab Med (2010) 0.80
Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation. Oncol Rep (2011) 0.80
Outcomes and mechanisms of ischemic preconditioning in liver transplantation. Hepatobiliary Pancreat Dis Int (2010) 0.79